Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells.

The ovarian hormone progesterone is essential for normal breast development and function. However, it is also implicated in breast cancer development. Progesterone signals through two nuclear receptors [progesterone receptor A (PRA) and progesterone receptor B (PRB)], which display striking differences in transcriptional activity when analyzed separately. The two species are coexpressed equally in normal breast, but expression becomes markedly disrupted in breast cancer, where a predominance of PRA is common. To determine the impact on PR transcriptional activity of the shift from coexpression of PRA and PRB, observed in normal cells, to predominance of PRA, common in cancers, we modeled these changes in PR expression patterns using an inducible model of PRA predominance. At short treatment times progestin regulation was directed toward transcriptional modulators, whereas longer exposure more frequently targeted genes associated with regulation of cell shape, adhesion, and metabolism, and a number of these targets acquired responsiveness only when PRA predominance was achieved. Consistent with this, overexpression of PRA altered progestin effects on cell-substrate attachment and focal adhesion signaling. Our data suggest that disrupted balance of PRA and PRB remodels progestin responsiveness and that altered regulation of morphology and adhesion are important components of altered progestin response in breast cancer.

[1]  R. Sutherland,et al.  Regulation of growth hormone and epidermal growth factor receptors by progestins in breast cancer cells. , 1985, Biochemical and biophysical research communications.

[2]  L. Murphy,et al.  Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells. , 1986, Cancer research.

[3]  J. V. Miller,et al.  Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques. , 1987, Endocrinology.

[4]  P. Chambon,et al.  The N-terminal region of the chicken progesterone receptor specifies target gene activation , 1988, Nature.

[5]  D. Edwards,et al.  Human progesterone receptor complexed with the antagonist RU 486 binds to hormone response elements in a structurally altered form. , 1989, Molecular endocrinology.

[6]  P Chambon,et al.  Two distinct estrogen‐regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. , 1990, The EMBO journal.

[7]  B. O’Malley,et al.  Regulation of progesterone receptor-mediated transcription by phosphorylation. , 1990, Science.

[8]  D. Edwards,et al.  Dimerization of mammalian progesterone receptors occurs in the absence of DNA and is related to the release of the 90-kDa heat shock protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  N. Hogg,et al.  Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. , 1991, The Journal of biological chemistry.

[10]  K. Horwitz,et al.  Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-independent and DNA-dependent stages: analysis with zinc finger mutants and the progesterone antagonist ZK98299. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  H. Gronemeyer,et al.  A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. , 1992, The Journal of biological chemistry.

[12]  D P McDonnell,et al.  Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. , 1993, Molecular endocrinology.

[13]  K. Horwitz,et al.  Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. , 1993, Molecular endocrinology.

[14]  D. McDonnell,et al.  The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells , 1994, Molecular and cellular biology.

[15]  K. Horwitz,et al.  A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. , 1994, Molecular endocrinology.

[16]  E. Vegeto,et al.  The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional acitivity , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  D. McDonnell,et al.  RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism. , 1994, The Journal of biological chemistry.

[18]  S. Aizawa,et al.  Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice , 1995, Nature.

[19]  J. Graham,et al.  Preferential Stimulation of Human Progesterone Receptor B Expression by Estrogen in T-47D Human Breast Cancer Cells (*) , 1995, The Journal of Biological Chemistry.

[20]  J. Graham,et al.  Characterization of progesterone receptor A and B expression in human breast cancer. , 1995, Cancer research.

[21]  C. Roberts,et al.  Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Horwitz,et al.  Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). , 1997, Molecular endocrinology.

[23]  J. Graham,et al.  Physiological action of progesterone in target tissues. , 1997, Endocrine reviews.

[24]  S. Rusconi,et al.  Definition of a negative modulation domain in the human progesterone receptor. , 1998, Molecular endocrinology.

[25]  M. Barcellos-Hoff,et al.  Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  K. Horwitz,et al.  An N-terminal Inhibitory Function, IF, Suppresses Transcription by the A-isoform but Not the B-isoform of Human Progesterone Receptors* , 1998, The Journal of Biological Chemistry.

[27]  Wen-rong Gong,et al.  Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross‐talk with estrogen receptor , 1998, The EMBO journal.

[28]  K. Horwitz,et al.  Convergence of Progesterone and Epidermal Growth Factor Signaling in Breast Cancer , 1998, The Journal of Biological Chemistry.

[29]  A. Bretscher.  Regulation of cortical structure by the ezrin-radixin-moesin protein family. , 1999, Current opinion in cell biology.

[30]  C. Clarke,et al.  Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells. , 1999, Molecular endocrinology.

[31]  N. Tran,et al.  Regulation of the expression and activity by progestins of a member of the SOX gene family of transcriptional modulators. , 1999, Journal of molecular endocrinology.

[32]  C. Clarke,et al.  Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. , 1999, The Journal of clinical endocrinology and metabolism.

[33]  S. Weed,et al.  Focal Adhesion Kinase: a regulator of focal adhesion dynamics and cell movement , 2000, Oncogene.

[34]  G. Hager,et al.  Characterization of transiently and constitutively expressed progesterone receptors: evidence for two functional states. , 2000, Molecular endocrinology.

[35]  A. Bretscher,et al.  ERM-Merlin and EBP50 protein families in plasma membrane organization and function. , 2000, Annual review of cell and developmental biology.

[36]  R. Cardiff,et al.  Impact of progesterone receptor on cell-fate decisions during mammary gland development. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  B. Bay,et al.  Progesterone induces focal adhesion in breast cancer cells MDA-MB-231 transfected with progesterone receptor complementary DNA. , 2000, Molecular endocrinology.

[38]  F. DeMayo,et al.  Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. , 2000, Science.

[39]  I. Zachary,et al.  Nuclear localization and apoptotic regulation of an amino-terminal domain focal adhesion kinase fragment in endothelial cells. , 2000, Biochemical and biophysical research communications.

[40]  J. Ruppert,et al.  Increase of GKLF messenger RNA and protein expression during progression of breast cancer. , 2000, Cancer research.

[41]  Donald P. McDonnell,et al.  The Opposing Transcriptional Activities of the Two Isoforms of the Human Progesterone Receptor Are Due to Differential Cofactor Binding , 2000, Molecular and Cellular Biology.

[42]  J. Black,et al.  Sp1 and krüppel‐like factor family of transcription factors in cell growth regulation and cancer , 2001, Journal of cellular physiology.

[43]  D. Edwards,et al.  Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. , 2001, Molecular cell.

[44]  K. Byth,et al.  Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. , 2001, Cancer research.

[45]  G. Coukos,et al.  Expression of Wilms' tumor suppressor gene (WT1) in human endometrium: regulation through decidual differentiation. , 2001, The Journal of clinical endocrinology and metabolism.

[46]  K. Horwitz,et al.  Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells* , 2002, The Journal of Biological Chemistry.

[47]  J. Brosens,et al.  Functional association of PR and CCAAT/enhancer-binding protein beta isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells. , 2002, Molecular endocrinology.

[48]  Neil J. McKenna,et al.  Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators , 2002, Cell.

[49]  K. H. Richter,et al.  Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis , 2002, Oncogene.

[50]  A. Bretscher,et al.  ERM proteins and merlin: integrators at the cell cortex , 2002, Nature Reviews Molecular Cell Biology.

[51]  Y. Wan,et al.  Overlapping but distinct gene regulation profiles by glucocorticoids and progestins in human breast cancer cells. , 2002, Molecular endocrinology.

[52]  G. Dressler,et al.  Expression of the PAX2 oncogene in human breast cancer and its role in progesterone-dependent mammary growth , 2002, Oncogene.

[53]  F. DeMayo,et al.  Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Daying Zhang,et al.  Selective Interactions of Krüppel-like Factor 9/Basic Transcription Element-binding Protein with Progesterone Receptor Isoforms A and B Determine Transcriptional Activity of Progesterone-responsive Genes in Endometrial Epithelial Cells* , 2003, Journal of Biological Chemistry.

[55]  Joyce Cheung-Flynn,et al.  The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness. , 2003, Endocrinology.

[56]  I. Cameron,et al.  Progesterone Up-Regulates WT1 mRna and Protein, and Alters the Relsative Expression of WT1 Transcripts in Cultured Endometrial Stromal Cells , 2003, The Journal of the Society for Gynecologic Investigation: JSGI.

[57]  J. Graham,et al.  Cytoskeletal responsiveness to progestins is dependent on progesterone receptor A levels. , 2003, Journal of Molecular Endocrinology.

[58]  J. Couchman,et al.  Regulation of cytoskeletal organization by syndecan transmembrane proteoglycans. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[59]  V. Yang,et al.  Krüppel-like Factor 4 Mediates p53-dependent G1/S Cell Cycle Arrest in Response to DNA Damage* , 2003, The Journal of Biological Chemistry.

[60]  P. Rouleau,et al.  Proinflammatory Activities of S100: Proteins S100A8, S100A9, and S100A8/A9 Induce Neutrophil Chemotaxis and Adhesion 1 , 2003, The Journal of Immunology.

[61]  Susan G. Hilsenbeck,et al.  Breast Cancer Patients with Progesterone Receptor PR-A-Rich Tumors Have Poorer Disease-Free Survival Rates , 2004, Clinical Cancer Research.

[62]  M. P. Quinlan.  Vinculin, VASP, and profilin are coordinately regulated during actin remodeling in epithelial cells, which requires de novo protein synthesis and protein kinase signal transduction pathways , 2004, Journal of cellular physiology.

[63]  N. Tran,et al.  Loss of Co-ordinate Expression of Progesterone Receptors A and B is an Early Event in Breast Carcinogenesis , 2002, Breast Cancer Research and Treatment.

[64]  G. Stewart,et al.  Nuclear import of N-terminal FAK by activation of the FcεRI receptor in RBL-2H3 cells , 2004 .

[65]  Donna J. Webb,et al.  FAK–Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly , 2004, Nature Cell Biology.

[66]  G. Chenevix-Trench,et al.  Germ‐line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen‐responsive proteins and the predominance of progesterone receptor A , 2004, Genes, chromosomes & cancer.

[67]  K. Byth,et al.  Expression of progesterone receptors A and B in the mouse ovary during the estrous cycle. , 2004, Endocrinology.

[68]  K. Bland,et al.  Nuclear Localization of KLF4 Is Associated with an Aggressive Phenotype in Early-Stage Breast Cancer , 2004, Clinical Cancer Research.

[69]  D. Schlaepfer,et al.  Multiple connections link FAK to cell motility and invasion. , 2004, Current opinion in genetics & development.

[70]  K. Horwitz,et al.  Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology. , 2005, Molecular endocrinology.